NEW YORK and CAMBRIDGE, Mass., Nov. 1, 2017 — BlueRock Therapeutics, a company developing cell-based therapies designed to alter the course of degenerative disease, today announced that its president and chief executive officer, Emile Nuwaysir, Ph.D., has been appointed to The Alliance for Regenerative Medicine […]
CAMBRIDGE, Mass., Oct. 26, 2017 — BlueRock Therapeutics, a company developing cellbased therapies designed to alter the course of degenerative disease, today announced the establishment of its corporate headquarters in Cambridge, Massachusetts, as well as the appointment of senior level team members who will support […]
Formalizes collaborations with McEwen Center for Regenerative Medicine at University Health Network, Centre for Commercialization of Regenerative Medicine Appoints Michael Scott, Ph.D., as Senior Vice President of Product Development and Toronto Operations TORONTO, Ontario and CAMBRIDGE, Mass., August 17, 2017 — BlueRock Therapeutics, which is […]
CEO, CTO and VP of Corporate Development appointments to propel BlueRock’s cell therapy development efforts CAMBRIDGE, Mass., June 27, 2017 — BlueRock Therapeutics today announced a trio of hires that bolster the company’s strategic and operational capabilities to develop breakthrough cell therapies for degenerative diseases […]
